Comparison Chart Aptamer Sciences Inc

Equities

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/06/2024 BST			5-day change	1st Jan Change
2,815 ^KRW	-1.57%		-1.23%	-21.91%

03-26	Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201	CI
2022	Aptamer Sciences Inc announced that it has received KRW 16.5 billion in funding from a group of investors	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	APTAMER SCIENCES INC	Other Biotechnology & Medical Research	-1.57%	-1.23%	-21.91%	-42.55%	-	34.54M